Fasken is a leading international business law and litigation firm with over 700 lawyers in offices in Canada, the United Kingdom, South Africa and China. They provide strategic advice to a broad range of clients including corporate clients, government agencies, regulatory authorities and not-for-profit bodies. Their Health Law Practice Group consists of a multidisciplinary team of health law experts experienced in addressing the complexities of health care delivery, administration, technology and regulation for both public and private health sector organizations. Fasken has sponsored the CRPBC since 1998 and has provided sessions on legal aspects relating to clinical research such as research contracts, privacy law and employment law. CRPBC meetings are generously hosted by Fasken at their downtown Vancouver offices.
Health Research BC is British Columbia's health research agency.
BC Support Unit (SUpport for People and Patient-Oriented Research and Trials) Unit is part of a national program to help health care research be more relevant and meaningful to patients, so that they get the best possible health care.
CenterWatch is a source of clinical trials information for both clinical research professionals and patients.
Clinical Trials BC advances British Columbia’s development as a world-class destination for clinical trials across BC’s hospitals, research institutions and communities. Their mission is to maximize the health, educational, and economic benefits of clinical trials to the citizens of BC. Priority areas include: clinical research navigation, professional development and training, regulatory, compliance and quality assurance, participant experience and clinical trial program development and support.
ClinicalTrials.gov is a database of privately and publicly funded clinical trials conducted around the world. Listings provide a summary of the study protocol, including the purpose, recruitment status, eligibility criteria, study locations and specific contact information.
Declaration of Helsinki was developed by the World Medical Association (WMA) as a statement of ethical principles for medical research involving human subjects, including research on identifiable human material and data. Current version: October 2013.
Food and Drug Administration (FDA) is responsible for protecting the public health by
assuring the safety, efficacy and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation.
Guideline for Good Clinical Practice (GCP) E6(R2) is an international ethical and scientific quality standard for designing, conducting, recording and reporting trials that involve the participation of human subjects. Compliance with this standard provides public assurance that the rights, safety and well-being of trial subjects are protected, consistent with the principles that have their origin in the Declaration of Helsinki, and that the clinical trial data are credible.
Health Canada: Drugs and Health Products
Health Canada: Therapeutic Products Directorate (TPD) is Canada’s regulator of prescription and medical devices for human use.
Health Canada: Natural and Non-prescription Health Products Directorate (NNHPD) is the regulating authority for natural health products and non-prescription drugs for sale in Canada.
ICH Guidelines provide important information on best clinical research practices.
It Starts With Me: This Canadian, clinical trials education website whose target audience is patients and caregivers is designed from a patient perspective to provide information and resources on what clinical trials are, and their importance in Canada.
LifeLabs provides laboratory testing services, which help physicians and other healthcare providers in the prevention, diagnosis, treatment and monitoring of disease and illness in patients. LifeLabs can provide specialized laboratory service for clinical research projects, either collection with shipping to central laboratories or local testing.
Office of the Information and Privacy Commissioner (OIPC) is independent from government and promotes and protects the information and privacy rights of British Columbians. OIPC provides oversight and enforcement of British Columbia’s Freedom of Information and Protection of Privacy Act (FIPPA) and Personal Information Protection Act (PIPA). FIPPA allows access to information held by public bodies (such as ministries, local governments, universities, crown corporations and hospitals) and determines how public bodies can collect, use and disclose personal information. PIPA sets out how private organizations (including businesses, charities, associations and labour organizations) may collect, use and disclose personal information.
Research Ethics BC, as part of the BC Academic Health Sciences Network, support a province-wide, harmonized system for research ethics reviews of studies conducted in multiple geographic areas involving the resources, people, patients or data from more than one BC research institution.
Tri-Council Policy Statement 2: The Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS or the Policy) is a joint policy of Canada’s three federal research agencies: the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC), and the Social Sciences and Humanities Research Council of Canada (SSHRC), or “the Agencies.”
